REPL - Replimune Group - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

REPL is currently covered by 9 analysts with an average price target of $11.09. This is a potential upside of $5.61 (102.37%) from yesterday's end of day stock price of $5.48.

Replimune Group's activity chart (see below) currently has 74 price targets and 88 ratings on display. The stock rating distribution of REPL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.49% with an average time for these price targets to be met of 192.45 days.

Highest price target for REPL is $9, Lowest price target is $2, average price target is $5.25.

Most recent stock forecast was given by EVAN SEIGERMAN from BMO on 23-Jul-2025. First documented stock forecast 14-Aug-2018.

Currently out of the existing stock ratings of REPL, 35 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$2

$-3.48 (-63.50%)

$27

17 days ago
(23-Jul-2025)

0/6 (0%)

$-1.34 (-40.12%)

Buy

$22

17 days ago
(23-Jul-2025)

1/18 (5.56%)

$12.6 (134.04%)

22

Buy

$3

$-2.48 (-45.26%)

$17

17 days ago
(23-Jul-2025)

3/5 (60%)

$-0.34 (-10.18%)

129

Buy

$3

$-2.48 (-45.26%)

$13

17 days ago
(23-Jul-2025)

1/2 (50%)

$-0.34 (-10.18%)

352

Buy

$4

$-1.48 (-27.01%)

$16

18 days ago
(22-Jul-2025)

6/12 (50%)

$1.19 (42.35%)

191

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is REPL (Replimune Group) average time for price targets to be met?

On average it took 192.45 days on average for the stock forecasts to be realized with a an average price target met ratio 33.49

Which analyst has the current highest performing score on REPL (Replimune Group) with a proven track record?

DO KIM

Which analyst has the most public recommendations on REPL (Replimune Group)?

Do Kim has 44 price targets and 26 ratings on REPL

Which analyst is the currently most bullish on REPL (Replimune Group)?

Matthew Luchini with highest potential upside - $15.9

Which analyst is the currently most reserved on REPL (Replimune Group)?

Evan Seigerman with lowest potential downside - -$3.48

Replimune Group in the News

H.C. Wainwright reiterates Buy rating on Replimune stock ahead of FDA decision

Investing.com – H.C. Wainwright has reiterated its Buy rating and $22.00 price target on Replimune Group (NASDAQ:REPL), currently trading at $9.40, as the company approaches a key regulatory decision date. According to InvestingPro data, analyst targets range from $16 to $31, with a strong consensus recommendation favoring the stock. The firm’s analysis focuses on Replimune’s...

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WOBURN, Mass., May 09, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired non-executive employees. The Company granted equity awards to 18 employees as a material inducement to commencing their employment with...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?